{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T18:05:20Z","timestamp":1776276320657,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.2353\/ajpath.2006.060159","type":"journal-article","created":{"date-parts":[[2006,12,13]],"date-time":"2006-12-13T19:54:42Z","timestamp":1166039682000},"page":"1353-1364","source":"Crossref","is-referenced-by-count":57,"title":["Effects of Glatiramer Acetate and Interferon-\u03b2 on Neurodegeneration in a Model of Multiple Sclerosis"],"prefix":"10.1016","volume":"169","author":[{"given":"Katharina","family":"Maier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antje V.","family":"Kuhnert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naimeh","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muriel B.","family":"S\u00e4ttler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria K.","family":"Storch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah K.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"B\u00e4hr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricarda","family":"Diem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.2353\/ajpath.2006.060159_bib1","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transection in the lesions of multiple sclerosis","volume":"338","author":"Trapp","year":"1998","journal-title":"N Engl J Med"},{"key":"10.2353\/ajpath.2006.060159_bib2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ana.1123","article-title":"Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions","volume":"50","author":"Peterson","year":"2001","journal-title":"Ann Neurol"},{"key":"10.2353\/ajpath.2006.060159_bib3","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1212\/WNL.43.4.662","article-title":"Interferon \u03b2-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial UBC MS\/MRI Study Group and the IFNB Multiple Sclerosis Study Group","volume":"43","author":"Paty","year":"1993","journal-title":"Neurology"},{"key":"10.2353\/ajpath.2006.060159_bib4","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1517\/14656566.2.7.1149","article-title":"Glatiramer acetate in the treatment of multiple sclerosis","volume":"2","author":"Sela","year":"2001","journal-title":"Expert Opin Pharmacother"},{"key":"10.2353\/ajpath.2006.060159_bib5","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0140-6736(00)04725-5","article-title":"Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study","volume":"357","author":"Comi","year":"2001","journal-title":"Lancet"},{"key":"10.2353\/ajpath.2006.060159_bib6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2165\/00023210-200317080-00002","article-title":"Interventions for the prevention of brain atrophy in multiple sclerosis: current status","volume":"17","author":"Rovaris","year":"2003","journal-title":"CNS Drugs"},{"key":"10.2353\/ajpath.2006.060159_bib7","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s004150170052","article-title":"Axonal metabolic recovery in multiple sclerosis patients treated with interferon \u03b2-1b","volume":"248","author":"Narayanan","year":"2001","journal-title":"J Neurol"},{"key":"10.2353\/ajpath.2006.060159_bib8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00415-003-0965-8","article-title":"Beta-interferon treatment does not always slow the progression of axonal injury in multiple sclerosis","volume":"250","author":"Parry","year":"2003","journal-title":"J Neurol"},{"key":"10.2353\/ajpath.2006.060159_bib9","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1212\/WNL.59.6.802","article-title":"Differential mechanisms of action of interferon-\u03b2 and glatiramer acetate in MS","volume":"59","author":"Yong","year":"2002","journal-title":"Neurology"},{"key":"10.2353\/ajpath.2006.060159_bib10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jns.2005.03.010","article-title":"Secretion of brain-derived neurotrophic factor by glatiramer acetate-reactive T-helper cell lines: implications for multiple sclerosis therapy","volume":"233","author":"Ziemssen","year":"2005","journal-title":"J Neurol Sci"},{"key":"10.2353\/ajpath.2006.060159_bib11","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1001\/archneur.62.4.563","article-title":"Interferon \u03b2 promotes nerve growth factor secretion early in the course of multiple sclerosis","volume":"62","author":"Biernacki","year":"2005","journal-title":"Arch Neurol"},{"key":"10.2353\/ajpath.2006.060159_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0165-5728(95)00124-7","article-title":"The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat","volume":"63","author":"Adelmann","year":"1995","journal-title":"J Neuroimmunol"},{"key":"10.2353\/ajpath.2006.060159_bib13","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.4049\/jimmunol.154.10.5536","article-title":"Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis","volume":"154","author":"Johns","year":"1995","journal-title":"J Immunol"},{"key":"10.2353\/ajpath.2006.060159_bib14","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1750-3639.1998.tb00194.x","article-title":"Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology","volume":"8","author":"Storch","year":"1998","journal-title":"Brain Pathol"},{"key":"10.2353\/ajpath.2006.060159_bib15","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1172\/JCI3022","article-title":"MHC haplotype-dependent regulation of MOG-induced EAE in rats","volume":"102","author":"Weissert","year":"1998","journal-title":"J Clin Invest"},{"key":"10.2353\/ajpath.2006.060159_bib16","doi-asserted-by":"crossref","first-page":"6214","DOI":"10.1523\/JNEUROSCI.21-16-06214.2001","article-title":"Acute neuronal apoptosis in a rat model of multiple sclerosis","volume":"21","author":"Meyer","year":"2001","journal-title":"J Neurosci"},{"key":"10.2353\/ajpath.2006.060159_bib17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1750-3639.2004.tb00047.x","article-title":"Mechanisms and time course of neuronal degeneration in experimental autoimmune encephalomyelitis","volume":"14","author":"Hobom","year":"2004","journal-title":"Brain Pathol"},{"key":"10.2353\/ajpath.2006.060159_bib18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/brain\/awh365","article-title":"Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis","volume":"128","author":"Diem","year":"2005","journal-title":"Brain"},{"key":"10.2353\/ajpath.2006.060159_bib19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0165-5728(97)00207-5","volume":"84","author":"van der Meide","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.2353\/ajpath.2006.060159_bib20","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0896-6273(88)90127-4","article-title":"Immunological, morphological, and electrophysiological variation among retinal ganglion cells purified by panning","volume":"1","author":"Barres","year":"1988","journal-title":"Neuron"},{"key":"10.2353\/ajpath.2006.060159_bib21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"10.2353\/ajpath.2006.060159_bib22","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1523\/JNEUROSCI.21-06-02058.2001","article-title":"Reduction of potassium currents and phosphatidylinositol 3-kinase-dependent AKT phosphorylation by tumor necrosis factor-(alpha) rescues axotomized retinal ganglion cells from retrograde cell death in vivo","volume":"21","author":"Diem","year":"2001","journal-title":"J Neurosci"},{"key":"10.2353\/ajpath.2006.060159_bib23","doi-asserted-by":"crossref","first-page":"6993","DOI":"10.1523\/JNEUROSCI.23-18-06993.2003","article-title":"Methylprednisolone increases neuronal apoptosis during autoimmune CNS inflammation by inhibition of an endogenous neuroprotective pathway","volume":"23","author":"Diem","year":"2003","journal-title":"J Neurosci"},{"key":"10.2353\/ajpath.2006.060159_bib24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jcla.20021","article-title":"Environment-dependent down-modulation of CD45 cell surface expression on polymorphonuclear cells","volume":"18","author":"Bohm","year":"2004","journal-title":"J Clin Lab Anal"},{"key":"10.2353\/ajpath.2006.060159_bib25","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/brain\/120.3.393","article-title":"Axonal damage in acute multiple sclerosis lesions","volume":"120","author":"Ferguson","year":"1997","journal-title":"Brain"},{"key":"10.2353\/ajpath.2006.060159_bib26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0002-9440(10)64537-3","article-title":"Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions","volume":"157","author":"Kornek","year":"2000","journal-title":"Am J Pathol"},{"key":"10.2353\/ajpath.2006.060159_bib27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S1474-4422(03)00408-3","article-title":"The use of quantitative magnetic-resonance-based techniques to monitor the evolution of multiple sclerosis","volume":"2","author":"Filippi","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.2353\/ajpath.2006.060159_bib28","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0165-5728(99)00074-0","article-title":"Magnetic resonance spectroscopy: imaging axonal damage in MS","volume":"98","author":"Arnold","year":"1999","journal-title":"J Neuroimmunol"},{"key":"10.2353\/ajpath.2006.060159_bib29","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1212\/WNL.57.12.2185","article-title":"The effect of IFN\u03b2-1b on the evolution of enhancing lesions in secondary progressive MS","volume":"57","author":"Brex","year":"2001","journal-title":"Neurology"},{"key":"10.2353\/ajpath.2006.060159_bib30","first-page":"S10","article-title":"Interferon \u03b2-lb is effective in relapsing-remitting multiple sclerosis. II MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. 1993","volume":"57","author":"Paty","year":"2001","journal-title":"Neurology"},{"key":"10.2353\/ajpath.2006.060159_bib31","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1212\/WNL.54.4.813","article-title":"Glatiramer acetate (Copaxone) treatment in relapsing-remitting MS: quantitative MR assessment","volume":"54","author":"Ge","year":"2000","journal-title":"Neurology"},{"key":"10.2353\/ajpath.2006.060159_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1191\/1352458505ms1234oa","article-title":"Axonal metabolic recovery and potential neuroprotective effect of glatiramer acetate in relapsing-remitting multiple sclerosis","volume":"11","author":"Khan","year":"2005","journal-title":"Multiple Sclerosis"},{"key":"10.2353\/ajpath.2006.060159_bib33","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/35040009","article-title":"Apoptosis in neurodegenerative disorders","volume":"1","author":"Mattson","year":"2000","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.2353\/ajpath.2006.060159_bib34","doi-asserted-by":"crossref","first-page":"7446","DOI":"10.1073\/pnas.97.13.7446","article-title":"T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies","volume":"97","author":"Kipnis","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2006.060159_bib35","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1073\/pnas.0530191100","article-title":"Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis","volume":"100","author":"Angelov","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2006.060159_bib36","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1073\/pnas.041609498","article-title":"Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma","volume":"98","author":"Schori","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2006.060159_bib37","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0168-0102(03)00217-7","article-title":"Axonal damage is reduced following glatiramer acetate treatment in C57\/bl mice with chronic-induced experimental autoimmune encephalomyelitis","volume":"47","author":"Gilgun-Sherki","year":"2003","journal-title":"Neurosci Res"},{"key":"10.2353\/ajpath.2006.060159_bib38","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1212\/WNL.54.5.1145","article-title":"Cladribine and progressive MS: clinical and MRI outcomes of a multicenter controlled trial. Cladribine MRI Study Group","volume":"54","author":"Rice","year":"2000","journal-title":"Neurology"},{"key":"10.2353\/ajpath.2006.060159_bib39","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1212\/WNL.53.4.751","article-title":"Quantitative MRI in patients with secondary progressive MS treated with monoclonal antibody Campath 1H","volume":"53","author":"Paolillo","year":"1999","journal-title":"Neurology"},{"key":"10.2353\/ajpath.2006.060159_bib40","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1084\/jem.189.5.865","article-title":"Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?","volume":"189","author":"Kerschensteiner","year":"1999","journal-title":"J Exp Med"},{"key":"10.2353\/ajpath.2006.060159_bib41","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1523\/JNEUROSCI.19-05-01708.1999","article-title":"Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor","volume":"19","author":"Batchelor","year":"1999","journal-title":"J Neurosci"},{"key":"10.2353\/ajpath.2006.060159_bib42","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.1523\/JNEUROSCI.20-14-05283.2000","article-title":"Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells","volume":"20","author":"Hammarberg","year":"2000","journal-title":"J Neurosci"},{"key":"10.2353\/ajpath.2006.060159_bib43","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1046\/j.1471-4159.2001.00497.x","article-title":"Differences in survival-promoting effects and intracellular signaling properties of BDNF and IGF-1 in cultured cerebral cortical neurons","volume":"78","author":"Yamada","year":"2001","journal-title":"J Neurochem"},{"key":"10.2353\/ajpath.2006.060159_bib44","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.1523\/JNEUROSCI.23-12-05149.2003","article-title":"Endogenously produced neurotrophins regulate survival and differentiation of cortical progenitors via distinct signaling pathways","volume":"23","author":"Barnabe-Heider","year":"2003","journal-title":"J Neurosci"},{"issue":"Suppl 2","key":"10.2353\/ajpath.2006.060159_bib45","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1038\/sj.cdd.4401504","article-title":"Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis","volume":"11","author":"S\u00e4ttler","year":"2004","journal-title":"Cell Death Differ"},{"key":"10.2353\/ajpath.2006.060159_bib46","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1750-3639.2004.tb00081.x","article-title":"Ciliary neurotrophic factor protects retinal ganglion cells from secondary cell death during acute autoimmune optic neuritis in rats","volume":"14","author":"Maier","year":"2004","journal-title":"Brain Pathol"},{"key":"10.2353\/ajpath.2006.060159_bib47","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jneuroim.2005.07.001","article-title":"Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: reversal by glatiramer acetate","volume":"167","author":"Azoulay","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.2353\/ajpath.2006.060159_bib48","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1471-4914(00)01909-2","article-title":"Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy","volume":"7","author":"Lassmann","year":"2001","journal-title":"Trends Mol Med"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010626053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010626053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T23:50:59Z","timestamp":1707436259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944010626053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0002944010626053"],"URL":"https:\/\/doi.org\/10.2353\/ajpath.2006.060159","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}